TAZAROTENE : A POTENT MEDICATION FOR ANTI- ACNE EFFECT

  • Unique Paper ID: 153119
  • PageNo: 582-587
  • Abstract:
  • Acne vulgaris is a common pilosebaceous unit inflammatory chronic illness. It frequently necessitates long-term therapy, leading in increased demand for popular topical drugs in order to achieve long-term compliance. Tazarotene foam 0.1 percent is a new tazarotene formulation. The efficacy and tolerance tests of the novel formulation are reviewed, and a potential use for the medication in the treatment of acne vulgaris is suggested.

Copyright & License

Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

BibTeX

@article{153119,
        author = {Ankur Yadav and Anupam Kumar Sachan and Sunil Kumar},
        title = {TAZAROTENE : A POTENT MEDICATION FOR ANTI- ACNE EFFECT},
        journal = {International Journal of Innovative Research in Technology},
        year = {},
        volume = {8},
        number = {5},
        pages = {582-587},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=153119},
        abstract = {Acne vulgaris is a common pilosebaceous unit inflammatory chronic illness. It frequently necessitates long-term therapy, leading in increased demand for popular topical drugs in order to achieve long-term compliance. Tazarotene foam 0.1 percent is a new tazarotene formulation. The efficacy and tolerance tests of the novel formulation are reviewed, and a potential use for the medication in the treatment of acne vulgaris is suggested.},
        keywords = {Retinoids, Efficacy, Safety, Tolerability.},
        month = {},
        }

Cite This Article

Yadav, A., & Sachan, A. K., & Kumar, S. (). TAZAROTENE : A POTENT MEDICATION FOR ANTI- ACNE EFFECT. International Journal of Innovative Research in Technology (IJIRT), 8(5), 582–587.

Related Articles